EGF and breast cancer: RGS16 locus is a site of genomic instability in (50% of 222) primary breast tumors and knockdown of RGS16 in breast cancer cell lines increases Epidermal Growth Factor (EGF) and Fetal Bovine Serum (FBS) initiated proliferation [19, 25].